Physician profile
Stacey Keppol
NPI 1093155103
$1,002.63
in general payments reported to CMS, 2019-2025
16 companies · $186 in 2025
The $186 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $221 · 2020: $102 · 2021: $217 · 2022: $153 · 2023: $86.83 · 2024: $37.49 · 2025: $186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $310.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $310.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $257.07 | 2019-2023 | Cequa |
| Carl Zeiss Meditec USA, INC. | $186.02 | 2025 | Cirrus Hd-Oct |
| Kala Pharmaceuticals, INC. | $75.30 | 2019-2021 | |
| Dompe US, INC. | $74.22 | 2019-2021 | |
| Thea Pharma INC. | $60.10 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $55.35 | 2020-2022 | |
| Biotissue Holdings INC. | $46.92 | 2019-2021 | |
| Rxsight INC | $44.71 | 2022-2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Alcon Vision LLC | $42.15 | 2023-2024 | Clareon |
| Akorn Operating Company LLC | $39.08 | 2021 | |
| Oyster Point Pharma, INC. | $30.04 | 2022 | |
| Aerie Pharmaceuticals, INC. | $26.97 | 2019-2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $21.42 | 2019 | |
| Bausch & Lomb Americas INC. | $16.33 | 2023 | Lotemax Sm |
| Allergan, INC. | $13.72 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $13.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacey Keppol listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.